Atlas Trials

Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine

Clinical trial NCT04850625 · COMPLETED

Trial details

NCT number
NCT04850625
Sponsor
Fudan University
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2020-01-15
Primary completion
2021-06-15
Enrollment
224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.